Document Details

ToughestAntagonist

Uploaded by ToughestAntagonist

University of Sunderland

Cheng Shu CHAW

Tags

extemporaneous preparations pharmaceutical preparations pharmacy medicine

Summary

This document contains lecture notes on extemporaneous dispensing and "special" preparations in pharmacy. It covers definitions, regulations, different approaches, and examples of common questions, and problems. The author is Cheng Shu CHAW and the document belongs to University of Sunderland.

Full Transcript

MPharm Programme Principles Of Extemporaneous Preparations and ‘Specials’ Cheng Shu CHAW 1 What is extemporaneous dispensing? Definition: Impromptu, performed with little or no preparation Also known as Compounding Preparation of a single medicinal product tailor made to the patient’s requireme...

MPharm Programme Principles Of Extemporaneous Preparations and ‘Specials’ Cheng Shu CHAW 1 What is extemporaneous dispensing? Definition: Impromptu, performed with little or no preparation Also known as Compounding Preparation of a single medicinal product tailor made to the patient’s requirements Unlicensed medicines Commonly known as “Specials” 2 What are ‘Specials’?  Different viewpoints on definition  A mixed bag of products and included cannabis based products  Anything which does not have a UK Marketing Authorisation (MA)  Imported items licensed in another country  Extemporaneous preparations  Batch produced, e.g. many sterile products such as ampoules or eye drops 3 Approaches In Different Countries USA- Hub pharmacy model. One Compounding pharmacy serving a community. Certain European countries e.g. Belgium-all compounding performed in Pharmacies UK-Use of Specials Manufacturers 4 Regulation 167 of the Human Medicines Regulations 2012 • Exemption from requirement of marketing authorisation • Need to fulfil the stated conditions 5 Guidance Note 14-MHRA  Guidance note on procurement of Specials  Must keep record of procurement in Pharmacy and report any Adverse Drug Reactions.  Specials manufacturer can only supply to Pharmacy, Doctor, Dentist or Wholesale Dealer (WL)  Maximum 30 day shelf life if no formal stability data of your own  Can download document from MHRA website  Prescriber awareness of unlicensed status & liability 6 Principle for the procurement and supply of specials 1. Establish a clinical need 5. Monitor and review 2. Understand the patient experience 3. Identify a preparation and supplier 4. Ensure effective governance 7 Principle for the procurement and supply of specials 8 Requirements: Facilities 1. Facilities  Space  Work bench with cleanable surfaces  Somewhere to store clean equipment  Raw materials’ storage  Equipment storage and cleaning  Control of cross contamination 9 Requirements: equipment 2. Equipment  Government stamped measures  Balances  Unguators or Topitec  Mortar and Pestle (avoid wood)  Stirring rod  Spatulas  Tiles  Method of heating e.g. water bath, microwave 10 Traditional Pharmaceutical Balances  Class A and B  Almost obsolete  Place weight on one side and ingredient on other on paper  Calibration unlikely 11 Electronic Balances  Check daily or before use with standard weights which are UKAS calibrated  Machines themselves should have maintenance and calibration schedule  Sitting is important: bubble should be centralised to level balance 12 Unguator  Closed system  Good operator protection  Nozzle attaches to pot to dispense ointment  Hygienic  Set mixing speeds/times 13 Requirements: documentations 3. Documentations  Reference materials, e.g. Martindale, BP, BPC etc.  Standard Operating Procedures  Worksheet including check signatures and manufacturing method  Labelling systems: Computerised PMR systems have difficulties with extemporaneous prescriptions  Certificates of analysis for raw materials 14 Example of worksheet 15 Cross Contamination  At worst a complete mix up, e.g. a product labelled as another product  Microbial: Bacteria or fungi. Does the product have a preservative system?  Physical: Particle, e.g. dust, plastic  Chemical: Residues or particles of another drug 16 Risk Analysis: A Twofold Exercise Risk To Patient • Error (both calculation and dispensing) • Cross Contamination • Nil or little formal stability data • No clinical trials • Excipient suitability, e.g. sugar or lanolin free Risk to Dispenser • Control of Substances Hazardous to Health or COSHH assessment • PPE available: safety glasses, gloves, masks & sleeve protectors • Risk to other employees e.g. fumes which can be harmful or unpleasant e.g. Cade Oil ”empyreumatic” odour 17 The Peppermint Water Case Death of a 3 week old baby due to the incorrect dilution of Chloroform Water Concentrate 18 A Basic Approach To Risk Analysis  Picture the worst case scenario  What would be the consequences to the patient?  How likely (frequency) is this type of error to occur?  Would the checking pharmacist or the patient be able to detect the error? 19 Common Problems with Specials Prescriptions  If short dated, will patient use up quantity prescribed within that time?  Cost if using specials company, very important if private prescription  Lack of details on prescriptions especially creams and ointments where no base is indicated  Computer generated prescriptions where unlicensed preparations are not in the standard menus  Finding a formula  Regional Differences with non-compendial formula, e.g. Knox Mouthwash means different things in different parts of UK 20 Common “Specials” Script Enquiries  Ingredients of creams or ointments expressed as % but don’t add up to 100%!  Readily available licensed medicine written generically, e.g. Duofilm Paint written as: Salicylic Acid 16.7%, Lactic Acid 16.7% in Flexible Collodion.  A licensed medicine should be dispensed wherever possible. 21 Sources of Formulae  Compendia e.g. BP, Martindale and etc.  Hospital-often continuation of treatment in primary care  GP’s own e.g. Dr Ives wart paint  Published literatures or journal articles available on internet 22 Availability of Raw Materials  Need to obtain a Pharmaceutical Grade, BP , PhEur or USP  Laboratory Grades (AnalaR or GPR) may be all that’s available  May be using a licensed medicine, e.g. crushing tablets, diluting a steroid cream such as Betnovate  Difficult to obtain small quantities of pure drug powders  Need to consider TSE-Transmissible Spongiform Encephalopathy e.g. Lanolin  Good practice to obtain a Certificate of Analysis  May need to use another unlicensed medicine ,e.g. imported tablets. Need to be assured of Quality 23 Formulation-Microbial Considerations  Is there any preservative system in the formula? This must be considered when allocating shelf life  Is the product prone to microbial growth, e.g. cream compared to ointment?  Traditional-Single strength Chloroform Water  NIPA’s such as Methyhydroxybenzoate and propyhydroxybenzoate  Widely used in Pharmaceuticals and Cosmetics  Cold water soluble salts available but raise pH of product which is often undesirable  Ester is soluble at 80oC-little effect on pH-more useful 24 Formulation General  Physical problems –cracking, caking, precipitation etc.  Chemical degradation-usually pH dependent  BP limits for actives are usually 95-105%. Published data may accept wider limits such as 90%.  Microbial-preservative system, closed pack shelf life may be longer than opened pack e.g. use 14 days after opening 25 Commonly Requested Non sterile Dosage Forms  For Application to the skin  E.g. Creams, Ointments, Pastes, Lotions, External Solutions  For Oral Ingestion-Liquids  E.g. Suspensions, Solutions, Mucilage  Traditional terms: Elixir, Mixture, Linctus  Now all referred to as Oral Solution/Suspension unless using a compendial title 26 Less Common Dosage Forms (Non Sterile)  Reefers (cigarettes injected with drug)  Capsules and Powders  Bars of Soap  Lozenges/Pastilles  Lollipops  Suppositories/Pessaries- need displacement value of ingredients 27 Prescriptions For External Use  Prescription says “Coal Tar Ointment”  Coal Tar Ointment BPC 1934 or other formula?  Coal Tar Solution BP (20%): Brown solution  Strong Coal Tar Solution BP (40%)  Coal Tar BP: Thick black semi-solid  Remember COSHH!!  MSDS= Material Safety Data Sheet  Ointment bases: WSP, YSP, Emulsifying Ointment 28 Prescriptions for External use Cont’d  Cream bases: Aqueous Cream, Hydrous Ointment (oily cream), Unguentum M (amphiphilic)  Common ingredients: Salicylic Acid Powder  Dithranol, Sulphur, Steroid Creams/Ointment  Can use crushed tablets or use injection, e.g. Genticin Injection 40mg/1ml to make Gentamicin Cream 29 Oral Liquids  Is drug soluble in vehicle at dose required?  If not could a suspension be prepared?  Crush tablets or use Powder  Use the highest strength tablets to reduce overall excipients  Check tablet characteristics: Controlled Release, Sugar Coated, Film Coated, Enteric Coated  Good Practice: Always use same brand and strength. Care with generics.  Good Practice: Standardise to dose/5ml or dose/1ml  May dilute injection fluid from ampoules 30 Making a Suspension From Tablets Crushing, grinding Wetting and pasting These steps are vital to give homogeneous product 31 Importance Of Calculation Skills  A full understanding of what’s required can prevent dispensing errors  Ensure correct clinical interpretation of prescription  Overdose or Sub-therapeutic dose 32 Importance Of Calculation Skills Cont’d  Simple %’s to 100%  Parts: 1:4, Five Parts Total. This is 20%.  ¼ is 25%  Relationship between mg/5ml and %  Use of International Units  Dealing with odd doses when making crushed tablet suspensions  Dilutions (Peppermint Water Case) 33 Beware of Complacency  We all know 1+1=2  Check this every day as a pharmacist  Errors are usually silly mistakes  Consequences can be tragic  Establish rules and routines  Standard Operating Procedures and Worksheets 34 Summary-Dealing with Prescription  Often lacking in details  Don’t take at face value  Usual clinical assessment  Has patient had medicine before, possibly from hospital?  Save details, e.g. worksheet or GN14 record  Consider shelf life, closed and open, pack size and storage conditions  Use your scientific knowledge 35 Summary-Managing Your patient  Collection and delivery arrangement  Good Practice-Establish a routine  Consider bank holidays  Logistics-especially fridge lines  Compliance, e.g. Administering 1ml may be easier than administering 5ml  Accurate dosing-Counselling, Oral Syringes  Pack down options- e.g. 1 bottle for home and 1 bottle for respite care 36 MPharm Programme Making Specials on an Industrial Scale 37 Licences and Regulations  Medicines Act 1968  Human Medicines regulation 2012  MHRA: Specials Manufacturing Licence  MHRA :Wholesale Dealers Licence  Retention of licence depends on successful MHRA inspections  Misuse of Drugs Act 1971  Licences issued by Home Office  Registered Pharmacy Premises  (Clinical Trial Directives) 38 Compliance With Other Regulations  Employment Law  Weights and Measures  Health and Safety  Waste Disposal and Environmental issues 39 The Guides • Orange Guide: Rules and Guidance for Pharmaceutical Manufacturers and Distributors • This document introduces the concepts of a Quality Assurance System and Good Manufacturing Practices • Green Guide: Rules and Guidance for Pharmaceutical Distributors 40 Specials Patients  Paediatric  Geriatric  Terminally ill  Drug Misusers  Special Needs  Tube fed  Allergies 41 Specials Manufacturing License Two Key Personnel  Head of Production  Head of Quality Control  These have both different and common responsibilities  Should be two individuals with relevant experiences & qualifications to the same level 42 Extemporaneous Dispensing in Industry  Cleanrooms  MHRA Licences  Operate a Quality Management System  Full GMP Compliance  SOP’s/QC worksheets/Environmental monitoring/ Training records  Validation System  Full audit trail  Perform risk assessments and in house risk mitigation techniques to prevent errors  Develop best practice 43 Scaling Up  Change from crushing tablets to using powder (API)  Need to QC test  Need TSE compliance certificate  Shelf life extension/Stability Testing (ICH)  Full set of Processing Equipment: Mixing, filling, packaging, Labelling, Bar Codes for shipping, shrink wrap/pallets  Bulk storage-Quarantine and Released 44 Scale Up Continued  Dispensing of Raw Materials  Chemical and microbial cleaning validation  Process validation  Cleaning large equipment-shower heads, floor drains, high pressure hoses  Drying and storage of cleaned equipment 45 Scale Up Cont’d  Methods of Heating-melting waxes, water  Source of Purified Water EP-daily monitoring of still  Use of Solvents e.g. Ethanol-spark proofing of equipment  Room changeover and work scheduling  Different staff for different parts of process 46 Reference • MHRA guidance note 14 • Royal Pharmaceutical Society. Professional guidance for the Procurement and Supply of Specials. 2015. 47

Use Quizgecko on...
Browser
Browser